Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Pulmonary embolism; PCR Covid-19 positive; PCR Covid-19 positive; Vomiting; aggravated food intake; Eating disorder; Condition aggravated; This is a spontaneous report from a contactable consumer (patient) downloaded from the Regulatory Authority-CZSUKL-21001137. An 85-year-old female patient received bnt162b2 (COMIRNATY), 1st dose on 11Jan2021 and 2nd dose on 01Feb2021, both via intramuscular at single dose for COVID-19 immunisation. Medical history included ongoing thyroid disorder and patient was on therapy (psychotropic medicinal products and food supplements) and varicose vein operation. The patient''s concomitant medications were not reported. After 7 days after the 2nd dose, there were some adverse reaction: aggravated condition, vomiting, aggravated food intake, eating disorder, all on 08Feb2021. She was transferred to the hospital, where she was diagnosed with massive pulmonary embolism with saturation 50% on 08Feb2021. PCR Covid-19 was positive on 09Feb2021. PCR Covid-19 positive 09Feb2021. Patient died on 09Feb2021. The cause of death was reported as embolism lung. Autopsy was done. Autopsy results was not available and will be informed about autopsy results. No follow-up attempts possible. Batch/Lot numbers cannot be obtained.; Reported Cause(s) of Death: Embolism lung
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166